Could psychedelics become a bipartisan issue?

As psychedelics gain popularity for their apparent efficacy at treating mental health ailments, could the supervised use of the drugs become a bipartisan issue?

Rep. Dan Crenshaw, R-Texas, and Rep. Ro Khanna, D-Calif., recently filed legislation directing the secretary of Health and Human Services to issue guidance on clinical trials for psychedelics.

Days later, the U.S. Food and Drug Administration published its first draft guidance on the use of psychedelic drugs for the potential treatment of certain medical conditions, including psychiatric disorders and addiction.